Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042956486> ?p ?o ?g. }
- W2042956486 endingPage "505" @default.
- W2042956486 startingPage "497" @default.
- W2042956486 abstract "Amphotericin B (AmphoB) remains the preferred therapy for invasive fungal infections despite many side effects, such as nephrotoxicity and electrolyte imbalance. Our previous study suggested that high sodium (Na) intake >4 mEq/kg per day may be associated with lower nephrotoxicity in extremely premature infants treated with AmphoB. Subsequently, it became a standard of care in our unit to administer Na >4 mEq/kg per day to extremely premature infants treated with AmphoB. The purpose of this study was to evaluate the effect of high Na intake > 4 mEq/kg per day on the incidence of AmphoB-induced nephrotoxicity among extremely premature infants with birth weight <1250 gm. All extremely premature infants with birth weight <1250 gm born between 1992 and 2004 and treated with AmphoB for systemic fungal infections were included in the study. The study infants were divided into two groups: a control (CL) group (1/1992–12/1999, n = 21) consisting of extremely premature infants given a maintenance Na intake during AmphoB therapy, and a high sodium intake (High Na) group (1/2000–12/2004, n = 16) consisting of extremely premature infants given a high Na intake >4 mEq/kg per day during AmphoB therapy. Nephrotoxicity was defined as serum creatinine levels >1 mg/dl, urinary output (UOP) < 1 ml/kg per hour or a decrease in UOP of 50%, compared with the previous 2 days, and persisting for at least 2 days. Invasive fungal infection was diagnosed in 5.7% of the infants (44/763 infants). Thirty-seven infants were eligible for the study and seven were excluded. There were no differences between the two groups in gestational age, birth weight, age at fungal infection diagnosis, length of AmphoB therapy, daily fluid intake or hyponatremia. Nephrotoxicity was significantly higher in the CL group than in the High Na group (13/21 vs. 3/16; P = 0.02). In the CL group, nephrotoxicity occurred at (mean ± SD) 1.9 ± 3.2 days after the initiation of AmphoB treatment and lasted for 5.5 ± 4.7 days. In this group, nephrotoxicity occurred in two of the 13 infants before the initiation of AmphoB therapy. In the High Na group, nephrotoxicity occurred before the start of AmphoB therapy in two of the three infants. In the third infant, nephrotoxicity lasted for 1 day. Mean Na intake was not different between the two groups during the 4-day period prior to AmphoB therapy. Mean Na intake during the first 10-day period of AmphoB therapy was significantly lower in the CL group (3.7 vs 6.2; P < 0.001). Conclusion: High Na intake was associated with a reduction in the incidence of AmphoB-induced nephrotoxicity in extremely premature infants with birth weight <1250 gm. We recommend the use of a high Na intake of >4 mEq/kg per day for extremely premature infants during Amphotericin B therapy." @default.
- W2042956486 created "2016-06-24" @default.
- W2042956486 creator A5020729809 @default.
- W2042956486 creator A5070316625 @default.
- W2042956486 creator A5070666787 @default.
- W2042956486 date "2009-03-01" @default.
- W2042956486 modified "2023-09-27" @default.
- W2042956486 title "Influence of sodium intake on Amphotericin B-induced nephrotoxicity among extremely premature infants" @default.
- W2042956486 cites W1485448547 @default.
- W2042956486 cites W1982326388 @default.
- W2042956486 cites W1986363367 @default.
- W2042956486 cites W1992638339 @default.
- W2042956486 cites W2008284011 @default.
- W2042956486 cites W2008519120 @default.
- W2042956486 cites W2009359145 @default.
- W2042956486 cites W2017046795 @default.
- W2042956486 cites W2019367173 @default.
- W2042956486 cites W2029529084 @default.
- W2042956486 cites W2031690303 @default.
- W2042956486 cites W2036887186 @default.
- W2042956486 cites W2041705779 @default.
- W2042956486 cites W2043873715 @default.
- W2042956486 cites W2046718172 @default.
- W2042956486 cites W2048610071 @default.
- W2042956486 cites W2051433245 @default.
- W2042956486 cites W2051629697 @default.
- W2042956486 cites W2057232181 @default.
- W2042956486 cites W2067549921 @default.
- W2042956486 cites W2074603551 @default.
- W2042956486 cites W2079550003 @default.
- W2042956486 cites W2082201571 @default.
- W2042956486 cites W2104856050 @default.
- W2042956486 cites W2113522006 @default.
- W2042956486 cites W2119046313 @default.
- W2042956486 cites W2125053939 @default.
- W2042956486 cites W2147276214 @default.
- W2042956486 cites W4233252020 @default.
- W2042956486 doi "https://doi.org/10.1007/s00467-008-1050-4" @default.
- W2042956486 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19082636" @default.
- W2042956486 hasPublicationYear "2009" @default.
- W2042956486 type Work @default.
- W2042956486 sameAs 2042956486 @default.
- W2042956486 citedByCount "28" @default.
- W2042956486 countsByYear W20429564862012 @default.
- W2042956486 countsByYear W20429564862013 @default.
- W2042956486 countsByYear W20429564862014 @default.
- W2042956486 countsByYear W20429564862015 @default.
- W2042956486 countsByYear W20429564862016 @default.
- W2042956486 countsByYear W20429564862017 @default.
- W2042956486 countsByYear W20429564862018 @default.
- W2042956486 countsByYear W20429564862021 @default.
- W2042956486 countsByYear W20429564862022 @default.
- W2042956486 crossrefType "journal-article" @default.
- W2042956486 hasAuthorship W2042956486A5020729809 @default.
- W2042956486 hasAuthorship W2042956486A5070316625 @default.
- W2042956486 hasAuthorship W2042956486A5070666787 @default.
- W2042956486 hasBestOaLocation W20429564861 @default.
- W2042956486 hasConcept C120665830 @default.
- W2042956486 hasConcept C121332964 @default.
- W2042956486 hasConcept C126189478 @default.
- W2042956486 hasConcept C126322002 @default.
- W2042956486 hasConcept C187212893 @default.
- W2042956486 hasConcept C2779083892 @default.
- W2042956486 hasConcept C2779234561 @default.
- W2042956486 hasConcept C2780306776 @default.
- W2042956486 hasConcept C29730261 @default.
- W2042956486 hasConcept C54355233 @default.
- W2042956486 hasConcept C61511704 @default.
- W2042956486 hasConcept C66322754 @default.
- W2042956486 hasConcept C71924100 @default.
- W2042956486 hasConcept C86803240 @default.
- W2042956486 hasConcept C90924648 @default.
- W2042956486 hasConceptScore W2042956486C120665830 @default.
- W2042956486 hasConceptScore W2042956486C121332964 @default.
- W2042956486 hasConceptScore W2042956486C126189478 @default.
- W2042956486 hasConceptScore W2042956486C126322002 @default.
- W2042956486 hasConceptScore W2042956486C187212893 @default.
- W2042956486 hasConceptScore W2042956486C2779083892 @default.
- W2042956486 hasConceptScore W2042956486C2779234561 @default.
- W2042956486 hasConceptScore W2042956486C2780306776 @default.
- W2042956486 hasConceptScore W2042956486C29730261 @default.
- W2042956486 hasConceptScore W2042956486C54355233 @default.
- W2042956486 hasConceptScore W2042956486C61511704 @default.
- W2042956486 hasConceptScore W2042956486C66322754 @default.
- W2042956486 hasConceptScore W2042956486C71924100 @default.
- W2042956486 hasConceptScore W2042956486C86803240 @default.
- W2042956486 hasConceptScore W2042956486C90924648 @default.
- W2042956486 hasIssue "3" @default.
- W2042956486 hasLocation W20429564861 @default.
- W2042956486 hasLocation W20429564862 @default.
- W2042956486 hasOpenAccess W2042956486 @default.
- W2042956486 hasPrimaryLocation W20429564861 @default.
- W2042956486 hasRelatedWork W1999104473 @default.
- W2042956486 hasRelatedWork W2007838125 @default.
- W2042956486 hasRelatedWork W2174999345 @default.
- W2042956486 hasRelatedWork W2355894302 @default.
- W2042956486 hasRelatedWork W2365805804 @default.
- W2042956486 hasRelatedWork W2409957712 @default.